Futures
Access hundreds of perpetual contracts
CFD
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Promotions
AI
Gate AI
Your all-in-one conversational AI partner
Gate AI Bot
Use Gate AI directly in your social App
GateClaw
Gate Blue Lobster, ready to go
Gate for AI Agent
AI infrastructure, Gate MCP, Skills, and CLI
Gate Skills Hub
10K+ Skills
From office tasks to trading, the all-in-one skill hub makes AI even more useful.
GateRouter
Smartly choose from 40+ AI models, with 0% extra fees
He Rong Technology New Stock Subscription Analysis: A high-end medical technology company focused on boron neutron capture therapy.
Horizon Technology (7799) will open for public subscription from September 3 to 5, and plans to list on the Taiwan Stock Exchange on September 15. As a high-tech medical company focusing on accelerator-based boron neutron capture therapy (AB-BNCT), Horizon Technology's listing has attracted significant market attention.
Core Advantages of the Company
He Rong Technology integrates key patents and technologies from Tsinghua University and the Industrial Technology Research Institute, providing comprehensive solutions ranging from site assessment, radiation shielding planning to the implementation of treatment planning systems. The company has received a 1.2 billion NT dollar order from Taipei Veterans General Hospital's AB-BNCT treatment center, expected to be completed and recognized as revenue by 2027, bringing significant growth momentum for future operations.
Research and Industry-Academia Collaboration
Horizon Technology announced on September 2nd the signing of a cooperation agreement with Tsinghua University to jointly establish the "Horizon-Tsinghua Joint Research and Development Center". This move not only strengthens the research and development capabilities of advanced medical technologies such as AB-BNCT but also promotes the practical application of innovative achievements, becoming an important model for industry-academia collaboration.
Subscription Details and Market Performance
Based on the closing price of 849 TWD on September 2, compared to the underwriting price of 600 TWD, the price difference per share reaches 249 TWD. During trading on September 3, the stock price of He Rong Technology reached a maximum of 861 TWD, an increase of 1.41%, reflecting the market's continued optimism about its performance after listing.
Market Positioning and Future Development
He Rong Technology not only occupies a leading position in the AB-BNCT field but also independently develops the boron neutron capture therapy drug BPA, which is expected to obtain drug certification in 2027. This will further strengthen the company's revenue stability and market competitiveness, giving it greater advantages in the high-end medical technology field.
This article is for reference only and does not constitute any investment advice. Investors should fully understand the relevant risks and seek the advice of professional financial advisors before making investment decisions.